Associated Papers
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.
Benjamin ER et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017
27657681 (PubMed )
Supplement: gim2016122x1.zip › Supplemental_Appendix_2_12152015.xlsx › Non-Classic
Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.
Koskenvuo JW et al.
Clinical Physiology and Functional Imaging, 2009
Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters.
Koskenvuo JW et al.
Journal of Inherited Metabolic Disease, 2008
Select a paper to view details